Yelei Guo

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

Chunmeng Wang, Zhiqiang Wu, Yao Wang et al. · Clinical Cancer Research · 2016 · 323 citations

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

Yao Wang, Meixia Chen, Zhiqiang Wu et al. · OncoImmunology · 2018 · 319 citations · Full text

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Hanren Dai, Zhiqiang Wu, Hejin Jia et al. · Journal of Hematology & Oncology · 2020 · 312 citations · Full text

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

Kaichao Feng, Yang Liu, Yelei Guo et al. · Protein & Cell · 2017 · 304 citations · Full text

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats

Yiling Si, Yali Zhao, Haojie Hao et al. · Diabetes · 2012 · 285 citations · Full text

Immunology, Biomedical Engineering, Insulin Signaling +24